Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -132,118 | -68,926 | -59,633 | -48,785 | -44,412 |
| Depreciation Amortization | 1,833 | 1,547 | 1,719 | 1,705 | 1,585 |
| Accounts receivable | N/A | 1,083 | 2,142 | 1,818 | -5,043 |
| Other Working Capital | 14,338 | 9,388 | 4,863 | 7,770 | -12,510 |
| Other Operating Activity | 15,808 | 5,239 | 5,115 | 3,748 | 10,958 |
| Operating Cash Flow | $-100,139 | $-51,669 | $-45,794 | $-33,744 | $-49,422 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 534 | -106,838 | 26,778 | -35,107 | 47,872 |
| PPE Investments | -4,817 | -238 | -695 | -4,324 | -1,420 |
| Net Acquisitions | -141,060 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-145,343 | $-107,076 | $26,083 | $-39,431 | $46,452 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 50,000 | N/A | 14,888 | 995 | 0 |
| Debt Repayment | -15,291 | -299 | -398 | -1,342 | -1,293 |
| Common Stock Issued | 258,228 | 139,478 | 15,000 | 81,825 | 359 |
| Common Stock Repurchased | -2,044 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | -110 | 0 | 0 |
| Financing Cash Flow | $290,893 | $139,179 | $29,380 | $81,478 | $-934 |
| Beginning Cash Position | 24,074 | 43,640 | 33,971 | 25,668 | 29,572 |
| End Cash Position | 69,485 | 24,074 | 43,640 | 33,971 | 25,668 |
| Net Cash Flow | $45,411 | $-19,566 | $9,669 | $8,303 | $-3,904 |
| Free Cash Flow | |||||
| Operating Cash Flow | -100,139 | -51,669 | -45,794 | -33,744 | -49,422 |
| Capital Expenditure | -4,817 | -238 | -695 | -4,324 | -1,420 |
| Free Cash Flow | -104,956 | -51,907 | -46,489 | -38,068 | -50,842 |